Comparing two acid reducers for upper stomach bleeding
Treatments studied
Part of Digestive system clinical trials.
This study compares two acid-reducing medications, keverprazan and pantoprazole, to see which is better at stopping bleeding from the upper digestive tract (stomach or food pipe). If you have had bleeding in your stomach or intestines, this trial could help determine the most effective treatment for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had signs of stomach or intestinal bleeding (like vomiting blood or dark, tarry stools) within the past 5 days.
- Your bleeding has been confirmed by an endoscopy to be from a source other than enlarged veins in your esophagus or stomach.
- You are between 18 and 75 years old.
- You are willing to participate and sign a consent form.
- You have not had surgery to remove part of your stomach or weight-loss surgery, and you do not have active cancer or serious organ disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a heartburn medication (pantoprazole) helps patients with liver cirrhosis who have had a procedure to treat enlarged veins in the esophagus or stomach. It looks at how well the medicine works when given after this procedure to prevent complications.
This study compares two treatments that reduce stomach acid after a bleeding ulcer has been repaired with an endoscope. It aims to find which one is better at preventing the ulcer from bleeding again.
This trial compares two acid-reducing medicines—Tegoprazan and Lansoprazole—to see which works better for stopping bleeding from a peptic ulcer. If you have a confirmed upper GI bleed from an ulcer, this study may help find the best treatment for you.
This trial tests a newer medication called vonoprazan against the standard treatment pantoprazole for patients with gastroesophageal reflux disease (GERD). The goal is to see which one works better for controlling symptoms like heartburn and acid reflux over 8 weeks.
This study compares two medications, rabeprazole and vonoprazan, to see which one works better at preventing ulcers that can form after a procedure to treat varices (enlarged veins) in the esophagus. If you have cirrhosis and varices, this trial may help reduce pain and bleeding after your treatment.
This trial tests whether a newer drug, tegoprazan, works as well as the standard drug lansoprazole for healing bleeding ulcers in the stomach or small intestine. You will get one of these drugs for 14 days and have a follow-up endoscopy to check healing.
Hear when a new Non-variceal Upper Gastrointestinal Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.